Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

StubHub (STUB) investors face Jan. 23 deadline as IPO class action targets cash-flow disclosures

StubHub (STUB) investors face Jan. 23 deadline as IPO class action targets cash-flow disclosures

StubHub shares traded at $13.34 midday Wednesday, down about 43% from their $23.50 IPO price. Two U.S. law firms notified investors they have until Jan. 23 to seek lead-plaintiff status in a securities class action tied to the September 2025 IPO. The suit alleges vendor-payment timing hurt free cash flow and made disclosures misleading. StubHub reported negative free cash flow of $4.6 million for the third quarter.
14 January 2026
Petrobras stock pops as CEO flags 1 million bpd at Tupi again — here’s what’s next

Petrobras stock pops as CEO flags 1 million bpd at Tupi again — here’s what’s next

Petrobras’ U.S.-listed shares rose 3.4% after CEO Magda Chambriard said the Tupi field hit 1 million barrels per day, matching 2019 levels. The company also restarted two nitrogen fertilizer plants in Brazil’s northeast. Petrobras’ preferred shares in São Paulo climbed 2.7%, outperforming the Bovespa index. Brent crude traded up 1.2% at $66.23 a barrel amid geopolitical tensions.
14 January 2026
India’s ₹3.25 lakh crore Rafale mega-buy heads to talks — Dassault, Thales and Safran shares in focus

India’s ₹3.25 lakh crore Rafale mega-buy heads to talks — Dassault, Thales and Safran shares in focus

India’s defence ministry will discuss a proposed ₹3.25 trillion deal to buy 114 Rafale jets from France this week, according to ANI. Most jets would be assembled in India, with 12–18 delivered ready-to-fly. Dassault Aviation shares closed down 0.9% in Paris after the reports. The deal could be signed by late 2026, with deliveries starting in 2030.
14 January 2026
Bitdeer stock jumps 11% as bitcoin rallies and Nvidia GB200 AI push lands

Bitdeer stock jumps 11% as bitcoin rallies and Nvidia GB200 AI push lands

Bitdeer shares surged about 11% to $14.18 by midday Wednesday as bitcoin rose 4.6%, lifting crypto mining stocks. The company reported a 339% year-over-year jump in December bitcoin output, citing higher self-mining hashrate. Bitdeer also began rolling out Nvidia GB200 NVL72 systems in Malaysia to expand its AI cloud services. A securities fraud class action was filed against Bitdeer this week.
CleanSpark stock jumps on Texas land deal for 600-MW AI data center buildout

CleanSpark stock jumps on Texas land deal for 600-MW AI data center buildout

CleanSpark shares rose 8.8% to $13.66 after the company announced plans to acquire up to 447 acres in Brazoria County, Texas, for an AI and high-performance computing data center. The site will initially support 300 MW, expandable to 600 MW, with a long-term grid power agreement. Bitcoin climbed 4%, while other U.S.-listed miners also gained. Deal terms and closing timeline remain undisclosed.
Eos Energy stock moves on new “Indensity” battery pitch aimed at AI data centers and tight sites

Eos Energy stock moves on new “Indensity” battery pitch aimed at AI data centers and tight sites

Eos Energy shares rose 1.3% to $17.04 midday after launching its Indensity battery storage system, which the company says can deliver 1 gigawatt-hour per acre and 4–16+ hours of storage. Trading volume hit 25.8 million shares. Sector peers showed mixed moves, with Fluence down and Stem up. Eos highlighted the system’s non-flammable zinc chemistry and cybersecurity features, but warned of risks tied to funding and project execution.
NIO stock drops again as EU tariff rethink and China sales slowdown hit sentiment

NIO stock drops again as EU tariff rethink and China sales slowdown hit sentiment

Nio shares fell 1.6% to $4.61 in New York late Wednesday morning as the EU revived a “minimum price” tariff option for Chinese EVs. The China Association of Automobile Manufacturers forecast vehicle sales growth will slow to 1% in 2026. Nio said it will continue its European expansion despite new trade conditions. EU tariffs on Chinese EVs can reach up to 35.3%.
Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings

Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings

Pfizer shares rose 1.4% to $25.51 Wednesday morning, outpacing a broader market decline. CEO Albert Bourla said the company misjudged the cash-pay obesity drug market and plans about 10 Phase 3 obesity trials in 2026. Investors are watching for Feb. 3 results and updates on late-stage trial launches. Pfizer expects no revenue growth before 2029 as it faces major patent expirations.
Transocean (RIG) stock rises as oil adds risk premium — what traders are watching next

Transocean (RIG) stock rises as oil adds risk premium — what traders are watching next

Transocean shares rose 1.4% to $4.35 Wednesday, tracking gains in offshore drillers after oil prices climbed on Iran supply concerns. Brent crude gained 1.2%, while U.S. inventories increased by 3.4 million barrels last week. Transocean recently secured a 302-day drillship contract with bp in Brazil, adding $120 million to its backlog. Investors await further rig contract announcements and earnings updates.
14 January 2026
Denison Mines stock (DNN) rises today as uranium price signals return; Phoenix permits in focus

Denison Mines stock (DNN) rises today as uranium price signals return; Phoenix permits in focus

Denison Mines shares rose 2.4% to $3.43 after Cosa Resources issued 1.96 million shares to Denison under a deferred-consideration deal. Uranium prices neared $100 per pound in long-term contracts, their highest since 2007, as utilities negotiated new supply agreements. Denison is advancing its Phoenix project in Saskatchewan, with federal permitting decisions expected this quarter.
Shopify’s AI shopping push puts checkout inside Google Gemini and Microsoft Copilot

Shopify’s AI shopping push puts checkout inside Google Gemini and Microsoft Copilot

Shopify unveiled a Universal Commerce Protocol with Google, allowing AI assistants to complete purchases inside chat and search platforms. Over 20 retailers and payment firms, including Visa and Mastercard, back the standard. Shopify shares fell 7.5% to $154.89 in late morning New York trading. Amazon dropped 2%, while Etsy slipped 0.3%.
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue shares rose 0.4% to $17.08 in mid-morning trading after Kimberly-Clark filed new deal documents with U.S. regulators. The stock remains about 5% below the value implied by the pending cash-and-stock takeover. Kenvue shareholders are set to vote on the deal Jan. 29. The transaction’s value fluctuates with Kimberly-Clark’s share price.
1 179 180 181 182 183 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop